Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras
- 29 February 2008
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 18 (4), 302-306
- https://doi.org/10.1016/j.trim.2007.10.009
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (13671250, 14370367, 17390355)
This publication has 20 references indexed in Scilit:
- T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-αNature Immunology, 2006
- A novel PKC regulates ERK activation and degranulation of cytotoxic T lymphocytes: Plasticity in PKC regulation of ERKEuropean Journal of Immunology, 2006
- Potent Farnesyltransferase Inhibitor ABT-100 Abrogates Acute Allograft RejectionThe Journal of Heart and Lung Transplantation, 2005
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Evidence for a p21 /Raf-1/MEK-1/ERK-2-independent Pathway in Stimulation of IL-2 Gene Transcription in Human Primary T LymphocytesOnline Journal of Public Health Informatics, 1999
- Blocked Ras Activation in Anergic CD4 + T CellsScience, 1996
- Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T CellsScience, 1996
- p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells.The Journal of Experimental Medicine, 1993
- Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation.The Journal of Experimental Medicine, 1993
- Stimulation of p21ras upon T-cell activationNature, 1990